Shanghai Allist Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Allist Pharmaceuticals has a total shareholder equity of CN¥4.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.4B and CN¥570.1M respectively. Shanghai Allist Pharmaceuticals's EBIT is CN¥1.3B making its interest coverage ratio -16.7. It has cash and short-term investments of CN¥3.0B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -16.7x |
| Cash | CN¥3.03b |
| Equity | CN¥4.86b |
| Total liabilities | CN¥570.05m |
| Total assets | CN¥5.43b |
Recent financial health updates
No updates
Recent updates
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Shares Bounce 43% But Its Business Still Trails The Market
Oct 08
Does Shanghai Allist Pharmaceuticals (SHSE:688578) Deserve A Spot On Your Watchlist?
Sep 23Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 30Should You Be Adding Shanghai Allist Pharmaceuticals (SHSE:688578) To Your Watchlist Today?
Apr 01Optimistic Investors Push Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Shares Up 26% But Growth Is Lacking
Mar 04Financial Position Analysis
Short Term Liabilities: 688578's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥544.3M).
Long Term Liabilities: 688578's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥25.8M).
Debt to Equity History and Analysis
Debt Level: 688578 is debt free.
Reducing Debt: 688578 has no debt compared to 5 years ago when its debt to equity ratio was 12.6%.
Debt Coverage: 688578 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688578 has no debt, therefore coverage of interest payments is not a concern.